How the disease comes:
The numbers of people affected by Hashimoto’s thyroiditis is very high and growing in all countries of the world, and often some already affected by hypothyroidism may become a target for this disease.
Driving this disease is the immune system that results in hypothyroidism with production of autoimmune thyroid antibodies.
But how is Hashimoto’s thyroiditis determined?
It is important first to refer to the diagnosis of the condition, as it is sometimes referred to the presence of anti-thyroid antibodies, which if detected above a certain level, trigger a diagnosis of Hashimoto’s, even if the antibodies have not yet penetrated the thyroid and begun to damage the glandular tissue.
In practice, some studies do not consider the mere presence of antibodies in the blood to be diagnostic evidence of Hashimoto’s but believe that such a diagnosis can be issued only when the thyroid gland is found to be damaged.
Based on this concept, it is specified that only some antibodies are of the antithyroid type while other antibodies do not appear to be referable to thyroiditis but to other autoimmune diseases such asRheumatoid Arthritis while the detected levels of antithyroid antibodies are elevated, but the thyroid tissue does not appear damaged. Thus, just seeing the presence of anti-thyroid antibodies is not enough to confirm a diagnosis.
Only a needle biopsy of thyroid glandular tissue will reveal whether or not there has been an infiltration of antithyroid antibodies with obvious signs of alteration.
- Treatment to cure and regress it.
If the thyroid is functioning well and and no hormonal imbalances are found, treatment may be more based on a lifestyle regimen that does not aggravate the thyroid and can prevent related disorders, whereas if medication is needed then therapy should be established that will be proportionate to the condition of the thyroid, levels of TSH thyroid hormone, and to systematic monitoring of the patient’s condition.
Generally, drug therapy(synthetic hormones) should be understood as continuing over time to treat the disease and also to achieve at least moderate regression.
